About Index Trending news
Analyze
Pricing
Protagonist Therapeutics

Protagonist Therapeutics

Work at Protagonist Therapeutics? Add yourself to this profile

Protagonist Therapeutics

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

Elsewhere

Alexa global traffic share

16 Jul 2015
$40,000,000
Venture capital (Series C)
Foresite Capital, RA Capital Management, Starfish Ventures, +4
Added by

Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease

Xconomy
04 Jun 2013
$14,000,000
Venture capital (Series B)
19 Sep 2006
$9,000,000
Venture capital (Series A)
Starfish Ventures, Lilly Ventures, QIC BioVentures